A phase II trial of intrapatient dose-escalated sorafenib in patients with metastatic renal cell carcinoma. (Q50947796)
Jump to navigation
Jump to search
scientific article published in May 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II trial of intrapatient dose-escalated sorafenib in patients with metastatic renal cell carcinoma. |
scientific article published in May 2012 |
Statements
A phase II trial of intrapatient dose-escalated sorafenib in patients with metastatic renal cell carcinoma. (English)
1 reference
Robert Amato
1 reference
Jim Zhai
1 reference
James Willis
1 reference
Somyata Saxena
1 reference
Melissa DeFoe
1 reference
1 May 2012
1 reference
10
1 reference
3
1 reference
153-158
1 reference
Identifiers
1 reference